High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism

in Journal of Endocrinology
Authors:
T H M Da Costa
Search for other papers by T H M Da Costa in
Current site
Google Scholar
PubMed
Close
,
D H Williamson
Search for other papers by D H Williamson in
Current site
Google Scholar
PubMed
Close
,
A Ward
Search for other papers by A Ward in
Current site
Google Scholar
PubMed
Close
,
P Bates
Search for other papers by P Bates in
Current site
Google Scholar
PubMed
Close
,
R Fisher
Search for other papers by R Fisher in
Current site
Google Scholar
PubMed
Close
,
L Richardson
Search for other papers by L Richardson in
Current site
Google Scholar
PubMed
Close
,
D J Hill
Search for other papers by D J Hill in
Current site
Google Scholar
PubMed
Close
,
I C A F Robinson
Search for other papers by I C A F Robinson in
Current site
Google Scholar
PubMed
Close
, and
C F Graham
Search for other papers by C F Graham in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Abstract

Transgenic mice were made by introducing extra copies of the mouse insulin-like growth factor-II (IGF-II) gene driven by the bovine keratin 10 promoter (BKVI). The adult plasma IGF-II levels were elevated at least three times in one line. In this line, there was a lower lipid content of both brown and white adipose depots at 2–4 months of age, and 40% less fat in the carcass at 7–9 months. The low lipid phenotype was not detected in the carcass at 2 weeks after birth. The lean characteristic was attributed to circulating IGF-II because the transgene was not expressed in fat. At 2–4 months of age, the transgenes oxidized more oral lipid, and less of this lipid was incorporated into the whole body and the epididymal fat. In contrast, the interscapular brown adipose tissue maintained lipid incorporation and lipoprotein lipase activity despite its reduced size. The altered activity of the brown adipose tissue may account for the gradual onset and persistence of the lean feature of the transgenic mice. There were no substantial changes in lipogenesis which could account for the low fat content. The plasma levels of IGF-I, insulin, glycerol, non-esterified fatty acids, triacylglycerols and glucose were not greatly changed and the pituitary GH content was within the normal range.

Journal of Endocrinology (1994) 143, 433–439